BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3617033)

  • 1. HLA antigens in Behçet's disease with refractory ocular attacks.
    Matsuki K; Juji T; Tokunaga K; Mochizuki M; Hayashi K; Fujino Y; Numaga J; Yamashita H
    Tissue Antigens; 1987 Apr; 29(4):208-13. PubMed ID: 3617033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on HLA system of family members with Behçet's disease].
    Ohno S; Ichiishi A; Awata K; Matsuda H
    Nippon Ganka Gakkai Zasshi; 1989 Feb; 93(2):215-7. PubMed ID: 2773703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behcet's disease associated with HLA-B51 and DRw52 antigens in Italians.
    Baricordi OR; Sensi A; Pivetti-Pezzi P; Perrone S; Balboni A; Catarinelli G; Filippi F; Melchiorri L; Moncada A; Mattiuz PL
    Hum Immunol; 1986 Nov; 17(3):297-301. PubMed ID: 2432045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behçet's disease and major histocompatibility complex class II antigens in Tunisians.
    Hamza M; Ayed K; Hamzaoui K; Bardi R
    Dis Markers; 1988; 6(4):263-7. PubMed ID: 3233881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A genetic study of Behçet's disease in Taiwan Chinese.
    Chung YM; Tsai ST; Liao F; Liu JH
    Tissue Antigens; 1987 Aug; 30(2):68-72. PubMed ID: 3672493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An HLA-D region restriction fragment associated with refractory Behçet's disease.
    Numaga J; Matsuki K; Mochizuki M; Minami M; Juji T
    Am J Ophthalmol; 1988 May; 105(5):528-33. PubMed ID: 2897165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Close association of HLA-Bw51 with Behçet's disease.
    Ohno S; Ohguchi M; Hirose S; Matsuda H; Wakisaka A; Aizawa M
    Arch Ophthalmol; 1982 Sep; 100(9):1455-8. PubMed ID: 6956266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological and molecular HLA typing in Italian Behçet's patients: significant association to B51-DR5-DQw3 haplotype.
    Balboni A; Pivetti-Pezzi P; Orlando P; Rubini M; Selvatici R; Accorinti M; Baricordi OR; Gandini E
    Tissue Antigens; 1992 Mar; 39(3):141-3. PubMed ID: 1598687
    [No Abstract]   [Full Text] [Related]  

  • 9. Human leukocyte antigen serologic and DNA typing of Behçet's disease and its primary association with B51.
    Mizuki N; Inoko H; Mizuki N; Tanaka H; Kera J; Tsuiji K; Ohno S
    Invest Ophthalmol Vis Sci; 1992 Nov; 33(12):3332-40. PubMed ID: 1358857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA antigens in a Japanese family with Behçet's disease.
    Hayasaka S; Kurome H; Noda S
    Graefes Arch Clin Exp Ophthalmol; 1994 Oct; 232(10):589-90. PubMed ID: 8001828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Behçet's disease and class II and III antigens of the major histocompatibility complex].
    Hamza M; Ayed K; Bardi R; Gorgi Y; Meddeb N
    Rev Rhum Mal Osteoartic; 1990 Jan; 57(1):59-61. PubMed ID: 2320926
    [No Abstract]   [Full Text] [Related]  

  • 12. Histocompatibility antigens associated with Behçet's disease in northern Han Chinese.
    Mineshita S; Tian D; Wang LM; Jian XY; Li SY; Fang GZ; Bian TY; Liao HS; Tsuchida M; Tanaka H
    Intern Med; 1992 Sep; 31(9):1073-5. PubMed ID: 1421711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of herpes simplex virus-induced erythema multiforme with the human leukocyte antigen DQw3.
    Kämpgen E; Burg G; Wank R
    Arch Dermatol; 1988 Sep; 124(9):1372-5. PubMed ID: 3415279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behçet's disease associated with one of the HLA-B51 subantigens, HLA-B* 5101.
    Mizuki N; Inoko H; Ando H; Nakamura S; Kashiwase K; Akaza T; Fujino Y; Masuda K; Takiguchi M; Ohno S
    Am J Ophthalmol; 1993 Oct; 116(4):406-9. PubMed ID: 8213969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological aspects of Behçet's and Vogt-Koyanagi-Harada's diseases.
    Ohno S
    Trans Ophthalmol Soc U K (1962); 1981 Sep; 101 (Pt 3)(3):335-41. PubMed ID: 6820735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behçet's disease: lack of correlation of clinical manifestations with HLA antigens.
    Müftüoğlu AU; Yazici H; Yurdakul S; Pazarli H; Ozyazgan Y; Tüzün Y; Altaç M; Yalçin B
    Tissue Antigens; 1981 Feb; 17(2):226-30. PubMed ID: 7233417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of HLA-DQw3 (TA10-) with type I diabetes occurs with DR3/4 but not DR1/4 patients.
    Tait BD; Mraz G; Harrison LC
    Diabetes; 1988 Jul; 37(7):926-9. PubMed ID: 3260201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunogenetic mechanism of Behçet's disease].
    Mizuki N; Ohno S; Kamata K; Nakamura S; Ishihara M; Sato K; Inaba G; Tsuji K; Inoko H
    Nippon Ganka Gakkai Zasshi; 1991 Aug; 95(8):783-9. PubMed ID: 1950836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Behçet's disease and HLA antigens--an association with a new specificity recognized by a monoclonal antibody].
    Nakayama T
    Hokkaido Igaku Zasshi; 1985 Sep; 60(5):643-52. PubMed ID: 2416665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-B51 may serve as an immunogenetic marker for a subgroup of patients with Behçet's syndrome.
    Chajek-Shaul T; Pisanty S; Knobler H; Matzner Y; Glick M; Ron N; Rosenman E; Brautbar C
    Am J Med; 1987 Oct; 83(4):666-72. PubMed ID: 3314492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.